| Ytd | 42.73% | |
| 1y | 166.67% |
| Open | 6.05 | Prev Close | 6.87 | Low | 5.73 | High | 6.53 | Mkt Cap | 80.85M |
| Vol | 307.89K | Avg Vol | 99.81K | EPS | -0.81 | P/E | -8.00 | Forward P/E | -23.30 |
| Beta | 1.49 | Short Ratio | 1.54 | Inst. Own | 1.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 6.92 | 200-d Avg | 5.63 | 1yr Est | 7.50 |
CARMEL, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE A
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday'